Abstract
Preliminary studies show that intranasal (i.n.) administration of BCG in mice induces M1 activation of alveolar macrophages (M∅) that increase TNF-α production and cyclooxygenase-2 (COX-2) expression but reduce constitutive peroxisome proliferator-activated receptor gamma (PPARγ) expression. However, COX-2 is catalytically inactive for prostaglandin E2 release, unlike COX-2 that is active in M1 activation in vitro by BCG. In this study, we determined the role of PPARγ for BCG-induced M1 activation in vivo and in vitro. We found that treatment of mice with GW9662, a PPARγ antagonist, prior to i.n. BCG, partially restored PPARγ expression, and decreased TNF-α production and COX-2 expression. But COX-2 was still inactive. The decreased effects on TNF-α and COX-2 were also observed when alveolar M∅ were treated in vitro with GW9662/BCG, but COX-2 was still active. Our results indicate that PPARγ upregulates M1 activation of alveolar M∅, but inactive COX-2 formation is independent of PPARγ in mycobacterial pulmonary inflammation.
Similar content being viewed by others
References
Shibata, Y., R.A. Henriksen, I. Honda, R.M. Nakamura, and Q.N. Myrvik. 2005. Splenic PGE2-releasing macrophages regulate Th1 and Th2 immune responses in mice treated with heat-killed BCG. Journal of Leukocyte Biology 78: 1281–1290.
Shibata, Y., H. Ohata, M. Yamashita, S. Tsuji, J.F. Bradfield, A. Nishiyama, R.A. Henriksen, and Q.N. Myrvik. 2007. Immunologic response enhances atherosclerosis-type 1 helper T cell (Th1)-to-type 2 helper T cell (Th2) shift and calcified atherosclerosis in Bacillus Calmette-Guerin (BCG)-treated apolipoprotein E-knockout (apo E(−/−)) mice. Translational Research 149: 62–69.
Shibata, Y., J. Gabbard, M. Yamashita, S. Tsuji, M. Smith, A. Nishiyama, R.A. Henriksen, and Q.N. Myrvik. 2006. Heat-killed BCG induces biphasic cyclooxygenase 2+ splenic macrophage formation—role of IL-10 and bone marrow precursors. Journal of Leukocyte Biology 80: 590–598.
Shinohara, T., T. Pantuso, S. Shinohara, M. Kogiso, Q.N. Myrvik, R.A. Henriksen, and Y. Shibata. 2009. Persistent inactivation of macrophage cyclooxygenase-2 in mycobacterial pulmonary inflammation. American Journal of Respiratory Cell and Molecular Biology 41: 146–154.
Yamashita, M., T. Shinohara, S. Tsuji, Q.N. Myrvik, A. Nishiyama, R.A. Henriksen, and Y. Shibata. 2007. Catalytically inactive cyclooxygenase 2 and absence of prostaglandin E2 biosynthesis in murine peritoneal macrophages following in vivo phagocytosis of heat-killed Mycobacterium bovis bacillus Calmette-Guerin. The Journal of Immunology 179: 7072–7078.
Yamashita, M., S. Tsuji, A. Nishiyama, Q.N. Myrvik, R.A. Henriksen, and Y. Shibata. 2007. Differential subcellular localization of COX-2 in macrophages phagocytosing heat-killed Mycobacterium bovis BCG. American Journal of Physiology. Cell Physiology 293: C184–C190.
Rangel Moreno, J., I. Estrada Garcia, M. De La Luz Garcia, D.A. Hernandez, R.M. Leon, and R. Hernandez Pando. 2002. The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 106: 257–266.
van der Pouw Kraan, T.C., L.C. Boeije, R.J. Smeenk, J. Wijdenes, and L.A. Aarden. 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. The Journal of Experimental Medicine 181: 775–779.
Harbrecht, B.G., Y.M. Kim, E.A. Wirant, R.L. Simmons, and T.R. Billiar. 1997. Timing of prostaglandin exposure is critical for the inhibition of LPS- or IFN-gamma-induced macrophage NO synthesis by PGE2. Journal of Leukocyte Biology 61: 712–720.
Pillinger, M.H., M.R. Philips, A. Feoktistov, and G. Weissmann. 1995. Crosstalk in signal transduction via EP receptors: prostaglandin E1 inhibits chemoattractant-induced mitogen-activated protein kinase activity in human neutrophils. Advances in Prostaglandin, Thromboxane, and Leukotriene Research 23: 311–316.
Shinomiya, S., H. Naraba, A. Ueno, I. Utsunomiya, T. Maruyama, S. Ohuchida, F. Ushikubi, K. Yuki, S. Narumiya, Y. Sugimoto, A. Ichikawa, and S. Oh-ishi. 2001. Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. Biochemical Pharmacology 61: 1153–1160.
Sheibanie, A.F., I. Tadmori, H. Jing, E. Vassiliou, and D. Ganea. 2004. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. The FASEB Journal 18: 1318–1320.
Pavlovic, S., B. Du, K. Sakamoto, K.M. Khan, C. Natarajan, R.M. Breyer, A.J. Dannenberg, and D.J. Falcone. 2006. Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. The Journal of Biological Chemistry 281: 3321–3328.
Rodriguez, A., A. Tjarnlund, J. Ivanji, M. Singh, I. Garcia, A. Williams, P.D. Marsh, M. Troye-Blomberg, and C. Fernandez. 2005. Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG. Vaccine 23: 2565–2572.
Chen, M., M. Divangahi, H. Gan, D.S. Shin, S. Hong, D.M. Lee, C.N. Serhan, S.M. Behar, and H.G. Remold. 2008. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. The Journal of Experimental Medicine 205: 2791–2801.
Haile, M., U. Schroder, B. Hamasur, A. Pawlowski, T. Jaxmar, G. Kallenius, and S.B. Svenson. 2004. Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis. Vaccine 22: 1498–1508.
Myrvik, Q.N., E.S. Leake, and S. Oshima. 1962. A study of macrophages and epitheloid-like cells from granulomatous (BCG-induced) lungs of rabbits. The Journal of Immunology 89: 745–751.
Reddy, R.C., V.G. Keshamouni, S.H. Jaigirdar, X. Zeng, T. Leff, V.J. Thannickal, and T.J. Standiford. 2004. Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands. American Journal of Physiology. Lung Cellular and Molecular Physiology 286: L613–L619.
Asada, K., S. Sasaki, T. Suda, K. Chida, and H. Nakamura. 2004. Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. American Journal of Respiratory and Critical Care Medicine 169: 195–200.
Chinetti, G., S. Griglio, M. Antonucci, I.P. Torra, P. Delerive, Z. Majd, J.C. Fruchart, J. Chapman, J. Najib, and B. Staels. 1998. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. The Journal of Biological Chemistry 273: 25573–25580.
Weber, S.M., K.T. Chambers, K.G. Bensch, A.L. Scarim, and J.A. Corbett. 2004. PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. American Journal of Physiology. Endocrinology and Metabolism 287: E1171–E1177.
Lee, Y.J., H.N. Suh, and H.J. Han. 2009. Effect of BSA-induced ER stress on SGLT protein expression levels and alpha-MG uptake in renal proximal tubule cells. American Journal of Physiology. Renal Physiology 296: F1405–F1416.
Ricote, M., A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79–82.
Malur, A., A.J. McCoy, S. Arce, B.P. Barna, M.S. Kavuru, A.G. Malur, and M.J. Thomassen. 2009. Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response. The Journal of Immunology 182: 5816–5822.
Ayoub, S.S., R.M. Botting, A.N. Joshi, M.P. Seed, and P.R. Colville-Nash. 2009. Activation of macrophage peroxisome proliferator-activated receptor-gamma by diclofenac results in the induction of cyclooxygenase-2 protein and the synthesis of anti-inflammatory cytokines. Molecular and Cellular Biochemistry 327: 101–110.
Jiang, C., A.T. Ting, and B. Seed. 1998. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82–86.
Almeida, P.E., A.R. Silva, C.M. Maya-Monteiro, D. Torocsik, H. D'Avila, B. Dezso, K.G. Magalhaes, H.C. Castro-Faria-Neto, L. Nagy, and P.T. Bozza. 2009. Mycobacterium bovis bacillus Calmette-Guerin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis. The Journal of Immunology 183: 1337–1345.
Collino, M., N.S. Patel, K.M. Lawrence, M. Collin, D.S. Latchman, M.M. Yaqoob, and C. Thiemermann. 2005. The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion. Kidney International 68: 529–536.
Cuzzocrea, S., B. Pisano, L. Dugo, A. Ianaro, N.S. Patel, R. Di Paola, T. Genovese, P.K. Chatterjee, F. Fulia, E. Cuzzocrea, M. Di Rosa, A.P. Caputi, and C. Thiemermann. 2004. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice. Critical Care Medicine 32: 457–466.
Hounoki, H., E. Sugiyama, S.G. Mohamed, K. Shinoda, H. Taki, H.O. Abdel-Aziz, M. Maruyama, M. Kobayashi, and T. Miyahara. 2008. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. Bone 42: 765–774.
Floyd, Z.E., and J.M. Stephens. 2002. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. The Journal of Biological Chemistry 277: 4062–4068.
He, F., J.A. Doucet, and J.M. Stephens. 2008. Caspase-mediated degradation of PPARgamma proteins in adipocytes. Obesity (Silver Spring) 16: 1735–1741.
Leesnitzer, L.M., D.J. Parks, R.K. Bledsoe, J.E. Cobb, J.L. Collins, T.G. Consler, R.G. Davis, E.A. Hull-Ryde, J.M. Lenhard, L. Patel, K.D. Plunket, J.L. Shenk, J.B. Stimmel, C. Therapontos, T.M. Willson, and S.G. Blanchard. 2002. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41: 6640–6650.
Majai, G., Z. Sarang, K. Csomos, G. Zahuczky, and L. Fesus. 2007. PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. European Journal of Immunology 37: 1343–1354.
Liu, D., B.X. Zeng, and Y. Shang. 2006. Decreased expression of peroxisome proliferator-activated receptor gamma in endotoxin-induced acute lung injury. Physiological Research 55: 291–299.
Culver, D.A., B.P. Barna, B. Raychaudhuri, T.L. Bonfield, S. Abraham, A. Malur, C.F. Farver, M.S. Kavuru, and M.J. Thomassen. 2004. Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis. American Journal of Respiratory Cell and Molecular Biology 30: 1–5.
Woerly, G., K. Honda, M. Loyens, J.P. Papin, J. Auwerx, B. Staels, M. Capron, and D. Dombrowicz. 2003. Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. The Journal of Experimental Medicine 198: 411–421.
Barna, B.P., D.A. Culver, S. Abraham, A. Malur, T.L. Bonfield, N. John, C.F. Farver, J.A. Drazba, B. Raychaudhuri, M.S. Kavuru, and M.J. Thomassen. 2006. Depressed peroxisome proliferator-activated receptor gamma (PPargamma) is indicative of severe pulmonary sarcoidosis: possible involvement of interferon gamma (IFN-gamma). Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 23: 93–100.
Bonfield, T.L., C.F. Farver, B.P. Barna, A. Malur, S. Abraham, B. Raychaudhuri, M.S. Kavuru, and M.J. Thomassen. 2003. Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. American Journal of Respiratory Cell and Molecular Biology 29: 677–682.
Standiford, T.J., V.G. Keshamouni, and R.C. Reddy. 2005. Peroxisome proliferator-activated receptor-{gamma} as a regulator of lung inflammation and repair. Proceedings of the American Thoracic Society 2: 226–231.
Wada, M., T.L. Saunders, J. Morrow, G.L. Milne, K.P. Walker, S.K. Dey, T.G. Brock, M.R. Opp, D.M. Aronoff, and W.L. Smith. 2009. Two pathways for cyclooxygenase-2 protein degradation in vivo. The Journal of Biological Chemistry 284: 30742–30753.
Singh, M., P. Chaudhry, S. Parent, and E. Asselin. 2012. Ubiquitin-proteasomal degradation of COX-2 in TGF-beta stimulated human endometrial cells is mediated through endoplasmic reticulum mannosidase I. Endocrinology 153: 426–437.
Tabas, I. 2010. The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circulation Research 107: 839–850.
Antonicelli, F., D. Brown, M. Parmentier, E.M. Drost, N. Hirani, I. Rahman, K. Donaldson, and W. MacNee. 2004. Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant Nacystelyn. American Journal of Physiology. Lung Cellular and Molecular Physiology 286: L1319–L1327.
Shibata, Y., A.P. Bautista, S.N. Pennington, J.L. Humes, and A. Volkman. 1987. Eicosanoid production by peritoneal and splenic macrophages in mice depleted of bone marrow by 89Sr. The American Journal of Pathology 127: 75–82.
Carlos, D., D.A. de Souza Junior, L. de Paula, M.C. Jamur, C. Oliver, S.G. Ramos, C.L. Silva, and L.H. Faccioli. 2007. Mast cells modulate pulmonary acute inflammation and host defense in a murine model of tuberculosis. The Journal of Infectious Diseases 196: 1361–1368.
Moskovitz, J., N.A. Jenkins, D.J. Gilbert, N.G. Copeland, F. Jursky, H. Weissbach, and N. Brot. 1996. Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proceedings of the National Academy of Sciences of the United States of America 93: 3205–3208.
Hiratsuka, S., O. Minowa, J. Kuno, T. Noda, and M. Shibuya. 1998. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proceedings of the National Academy of Sciences of the United States of America 95: 9349–9354.
Kogiso, M., A. Nishiyama, T. Shinohara, M. Nakamura, E. Mizoguchi, Y. Misawa, E. Guinet, M. Nouri-Shirazi, C.K. Dorey, R.A. Henriksen, and Y. Shibata. 2011. Chitin particles induce size-dependent but carbohydrate-independent innate eosinophilia. Journal of Leukocyte Biology 90: 167–176.
Acknowledgments
This work was supported by NIH RO1 HL71711, DOD DAMD 17-03-1-0004, Bankhead-Coley Cancer Research Program 06BS-04-9615, and the Charles E. Schmidt Biomedical Foundation (YS). The authors thank Dr. Ikuro Honda, Japan BCG Laboratory, Tokyo, for providing BCG for this study. Authors wish to thank Traci Pantuso for her technical assistance. This paper is dedicated to the memory of Ruth Ann Henriksen (Deceased April 28, 2011) whose lively intellectual exchanges will be missed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kogiso, M., Shinohara, T., Dorey, C.K. et al. Role of PPARγ in COX-2 Activation in Mycobacterial Pulmonary Inflammation. Inflammation 35, 1685–1695 (2012). https://doi.org/10.1007/s10753-012-9486-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-012-9486-x